Nova Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Nova Financial's NBIX Position: Q3 2026 in Review
Nova Financial opened a new position in Neurocrine Biosciences (NBIX) in Q3 2026: 50 shares worth $7.09K. The stake represents ﹤0.01% of the portfolio and ranks #608 among its holdings.
766 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Nova Financial held 50 shares of Neurocrine Biosciences worth $7.09K as of Q3 2026.
- Neurocrine Biosciences was a new Nova Financial position in Q3 2026.
- Neurocrine Biosciences made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #608 holding.
- 766 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.